Skip to main content
. 2021 Jan 27;224(6):1039–1047. doi: 10.1093/infdis/jiab043

Figure 5.

Figure 5.

Model-predicted cure rates at different treatment lengths for both bedaquiline, delamanid, and linezolid (BDL) and isoniazid, rifampicin, pyrazinamide, and ethambutol (HRZE) regimens. Dashed line represents 85%, solid line 90% and dotted line 95% cure rate. HRZE regimen included 25-mg/kg isoniazid, 10-mg/kg rifampicin, 150-mg/kg pyrazinamide, and 100-mg/kg ethambutol. BDL regimen included 25-mg/kg bedaquiline, 2.5-mg/kg delamanid, and 100-mg/kg linezolid.